Author:
Schofield Peter W.,Finnie Sally,Yong Yun Ming
Publisher
Springer Science and Business Media LLC
Subject
Neurology (clinical),General Neuroscience
Reference80 articles.
1. Wesson DW, Wilson DA, Nixon RA. Should olfactory dysfunction be used as a biomarker of Alzheimer’s disease? Expert Rev Neurother. 2010;10:633–5. doi: 10.1586/ern.10.33 . A concise account of the issues relating to olfactory testing in the early detection of AD.
2. Albersa MW, Kayec J, Murphyd C, Wingfielde A, Boxerg AL, Buchmanf AS, et al. At the interface of sensory and motor dysfunctions and Alzheimer’s disease. Alzheimer Dement. 2014; An important, broad systematic summary, examining sensory and motor changes in AD.
3. Amieva H, Jacqmin-Gadda H, Orgogozo JM, Le Carret N, Helmer C, Letenneur L, et al. The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study. Brain. 2005;128(Pt 5):1093–101. doi: 10.1093/brain/awh451 .
4. Jack CR, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010;9(1):119–28.
5. Jack CR, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12(2):207–16. doi: 10.1016/s1474-4422(12)70291-0 .
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献